Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CURE® Announces Call for Nominations for GBM Heroes to Be Recognized at Night of Celebration During 21st Annual Scientific Meeting of Society for Neuro-Oncology
  • USA - English


News provided by

CURE magazine

Aug 24, 2016, 12:15 ET

Share this article

Share toX

Share this article

Share toX


Plainsboro, N.J. (PRWEB) August 24, 2016 -- CURE® magazine is calling for nominations for its Glioblastoma (GBM) Heroes who will be recognized at a gala celebration in Scottsdale, Ariz., on Nov. 18, during the 21st Annual Scientific Meeting of the Society for Neuro-Oncology. Fran Drescher—actress, author, health advocate, cancer survivor and founder of the Cancer Schmancer Movement—will be the guest speaker at the second annual event.

“We are proud to recognize and celebrate the individuals who have excelled in their efforts to raise awareness and education around glioblastoma," said Mike Hennessy Jr., president of CURE Media Group.

Post this

CURE magazine’s GBM Heroes Recognition program, sponsored by global oncology company Novocure, is accepting nominations from patients, healthcare professionals and advocates for GBM Heroes who have made a difference in the lives of people with GBM. Four winners and the individuals who nominated them will join CURE in Scottsdale to be honored at the 2nd Annual GBM Heroes Recognition.

“We are proud to recognize and celebrate the individuals who have excelled in their efforts to raise awareness and education around glioblastoma. We are also pleased to welcome award-winning actress, author and cancer advocate, Fran Drescher, as the guest speaker and look forward to her insight as a cancer survivor and strong advocate for cancer prevention and early detection,” said Mike Hennessy Jr., president of CURE Media Group.

Glioblastoma multiforme is the most aggressive and most common form of primary brain tumor in the U.S. and affects approximately 10,000 people every year. The median overall survival time from initial diagnosis is 15 months with optimal treatment; median survival from the time of tumor recurrence is 3 to 5 months without additional effective treatments.

Fran Drescher is a 16-year uterine cancer survivor. She is well recognized for her portrayal as “Miss Fine” in the hit series The Nanny, for which she received two Emmy and two Golden Globe nominations. She is the author of New York Times best-sellers Cancer Schmancer and Enter Whining, as well as a children’s book entitled Being Wendy. As a cancer advocate and founder of the Cancer Schmancer Movement, she focuses on a three-pronged approach to fighting the disease: early detection, prevention and advocacy.

GBM Hero nomination forms are available at http://www.curetoday.com/events/gbm and will be accepted through Sept. 15. Completed forms may be e-mailed to GBMheroes(at)curetoday(dot)com or mailed to CURE, Attention: GBM Heroes Award, Office Center at Princeton Meadows, 666 Plainsboro Rd., Building 300, Plainsboro, N.J. 08536. Reservations to attend the 2016 GBM Heroes award ceremony, which will be held at the Fairmont Scottsdale Princess in Scottsdale, may be made by visiting the website above and clicking on RSVP.

About CURE magazine
CURE magazine is CURE Media Group’s flagship product and an indispensable guide to every stage of the cancer continuum. With nearly 1 million readers who include cancer patients, cancer centers and advocacy groups, CURE is the largest consumer publication in the U.S. that focuses solely on cancer. CURE Media Group was acquired in 2014 by Michael J. Hennessy Associates, Inc. (MJH), and joined CURE with MJH’s acclaimed OncLive® (http://www.onclive.com) platform of resources for the practicing oncologist.

About Novocure
Novocure is a global oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. Headquartered in Jersey Isle, Novocure’s US operations are based in Portsmouth, N.H., and New York, N.Y. The company also has offices in Switzerland, Germany and Japan and a research Center in Haifa, Israel.

About Cancer Schmancer
Cancer Schmancer, a tax-exempt organization based in Malibu, Calif., was founded by Fran Drescher. The organization’s mission is to save lives by shifting the nation’s focus from just searching for a cure for cancer to prevention and early detection. The Cancer Schmancer Movement is a three-pronged organization dedicated to early cancer detection, prevention and policy change.

For more information, contact:
For CURE magazine: Becky Taylor, 609-240-6886 or becky(at)btaylorpa(dot)com
For Cancer Schmancer: info(at)cancerschmancer(dot)org

Becky Taylor, CURE magazine, http://www.curetoday.com/, +1 609-240-6886, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.